Extendicare Inc. (TSE:EXE – Get Free Report) traded up 11.5% on Wednesday . The stock traded as high as C$17.78 and last traded at C$17.78. 194,920 shares traded hands during mid-day trading, an increase of 9% from the average session volume of 178,940 shares. The stock had previously closed at C$15.94.
Analyst Upgrades and Downgrades
EXE has been the topic of several analyst reports. National Bankshares increased their price objective on Extendicare from C$16.10 to C$17.50 and gave the company an “outperform” rating in a research note on Wednesday, October 8th. National Bank Financial upgraded shares of Extendicare to a “strong-buy” rating in a research note on Wednesday, July 16th. CIBC set a C$18.00 target price on shares of Extendicare and gave the company an “outperform” rating in a report on Monday, September 22nd. Finally, Cibc World Mkts raised Extendicare to a “strong-buy” rating in a research report on Monday, September 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, Extendicare has a consensus rating of “Moderate Buy” and an average price target of C$15.20.
Read Our Latest Stock Analysis on Extendicare
Extendicare Trading Up 12.0%
Extendicare Announces Dividend
The company also recently declared a monthly dividend, which will be paid on Monday, November 17th. Investors of record on Monday, November 17th will be issued a dividend of $0.042 per share. This represents a c) dividend on an annualized basis and a yield of 2.8%. The ex-dividend date of this dividend is Friday, October 31st. Extendicare’s dividend payout ratio (DPR) is presently 50.57%.
About Extendicare
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Featured Stories
- Five stocks we like better than Extendicare
- What is a penny stock? A comprehensive guide
- Papa John’s $2.7 Billion Takeover Bid: A Price on Untapped Value
- 3 Small Caps With Big Return Potential
- Is Qualcomm Up 40% or Down 20%? 2 Contrarian Takes
- Health Care Stocks Explained: Why You Might Want to Invest
- Guardian Pharmacy Stock Pops on Q3 Strength and Upbeat Forecast
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
